422 filings
8-K
SAVA
Cassava Sciences Inc
15 Apr 24
Redemption Date Announced for Warrants
4:01pm
DEF 14A
SAVA
Cassava Sciences Inc
Definitive proxy
26 Mar 24
8:11am
ARS
2023 FY
SAVA
Cassava Sciences Inc
22 Mar 24
Annual report to shareholders
9:00am
10-K
2023 FY
SAVA
Cassava Sciences Inc
Annual report
28 Feb 24
4:01pm
8-K
SAVA
Cassava Sciences Inc
28 Feb 24
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
9:22am
8-K
ybf jsem3
7 Feb 24
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
9:20am
CERT
qvn3ouchro9k
3 Jan 24
Certification of approval for exchange listing
4:24pm
424B2
wtl2obhv vd3kd
3 Jan 24
Prospectus for primary offering
4:22pm
8-A12B
cdp9024 ti0d7b3nid
3 Jan 24
Registration of securities on exchange
4:18pm
8-K
00cm6
3 Jan 24
Entry into a Material Definitive Agreement
9:10am
8-A12G
wy5ahdk61rr
2 Jan 24
Registration of securities
9:10am
8-K
wibcqh9lvblki5qgt
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
8-K
1cio529x85ke2
11 Dec 23
Cassava Sciences Appoints
4:18pm
8-K
vydy6n01bm
7 Nov 23
Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results
9:08am
8-K
ox80b78dvq0x97faijn
13 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:17pm
UPLOAD
b7ojvtj4nx
14 Aug 23
Letter from SEC
12:00am
CORRESP
f7wd08vmvvr5vv9t53xo
10 Aug 23
Correspondence with SEC
12:00am
8-K
qrrm9f6nw1qity9 lin8
3 Aug 23
Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates
9:12am